Zhongsheng Tong

发表论文 44 篇 · 总被引 788 次 · h-index 15

代表论文

• Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial (2023 · Acta Pharmaceutica Sinica B · 被引 60)
• Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway (2021 · Molecular Therapy · 被引 56)
• Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial (2024 · Journal of Clinical Oncology · 被引 47)
• Chinese expert consensus on the clinical diagnosis and treatment of advanced breast cancer (2018) (2020 · Cancer · 被引 37)
• Decreasing Eukaryotic Initiation Factor 3C (EIF3C) Suppresses Proliferation and Stimulates Apoptosis in Breast Cancer Cell Lines Through Mammalian Target of Rapamycin (mTOR) Pathway (2017 · Medical Science Monitor · 被引 33)
• <p>MiR-223-3p targeting epithelial cell transforming sequence 2 oncogene inhibits the activity, apoptosis, invasion and migration of MDA-MB-468 breast cancer cells</p> (2019 · OncoTargets and Therapy · 被引 26)